Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $11.87 | Prev. Close $11.84 | Circuit Range N/A |
Day Range $11.32 - $12.54 | Year Range $1.34 - $14.70 | Volume 19,171 |
Average Traded $11.99 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $11.87 | $12.85 | +0.00% |
10-Jun-26 | $11.87 | $12.85 | +6.73% |
08-Jun-26 | $13.59 | $12.04 | -8.09% |
05-Jun-26 | $14.07 | $13.10 | -6.76% |
04-Jun-26 | $12.55 | $14.05 | +14.88% |
03-Jun-26 | $12.26 | $12.23 | -3.93% |
02-Jun-26 | $12.19 | $12.73 | +8.16% |